Clinical trials
Active, not recruiting Phase 1/2 trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
674 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 7 |
| 2011 | 7 |
| 2012 | 7 |
| 2013 | 9 |
| 2014 | 13 |
| 2015 | 14 |
| 2016 | 28 |
| 2017 | 42 |
| 2018 | 34 |
| 2019 | 67 |
| 2020 | 72 |
| 2021 | 72 |
| 2022 | 90 |
| 2023 | 83 |
| 2024 | 65 |
| 2025 | 42 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 674 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 39 |
| National Cancer Institute (NCI) | 36 |
| Memorial Sloan Kettering Cancer Center | 22 |
| AstraZeneca | 15 |
| Hoffmann-La Roche | 12 |
| n-Lorem Foundation | 10 |
| Novartis Pharmaceuticals | 9 |
| GlaxoSmithKline | 8 |
| Mayo Clinic | 8 |
| National Heart, Lung, and Blood Institute (NHLBI) | 8 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 65 |
| Breast Neoplasms | 40 |
| Neoplasms | 32 |
| Colorectal Neoplasms | 31 |
| Neoplasm Metastasis | 29 |
| Melanoma | 24 |
| Multiple Myeloma | 23 |
| Lung Neoplasms | 22 |
| Prostatic Neoplasms | 21 |
| Recurrence | 21 |
Trials
Showing 1 to 25 of 674. Each trial links to its page on Pharma Observatory.
574 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.